PDUFA reauthorization, FDA reform will not hold Congress in session -- FDA's Schultz.
This article was originally published in The Tan Sheet
Executive Summary
FDA REFORM/PDUFA REAUTHORIZATION WILL NOT KEEP CONGRESS IN SESSION following passage of the appropriations bills, FDA Deputy Commissioner for Policy William Schultz warned at a Sept. 3 Food & Drug Law Institute meeting in Washington DC. "Important as [the Prescription Drug User Fee Act] is, it is not going to hold Congress in session," Schultz maintained. "There is a very good chance that legislation will pass," Schultz said, "but unfortunately there is also a very real risk that it won't."